According to our LPI (LP Information) latest study, the global Pet Therapeutics market size was valued at US$ million in 2023. With growing demand in downstream market, the Pet Therapeutics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Pet Therapeutics market. Pet Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pet Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pet Therapeutics market.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 31%.
Key Features:
The report on Pet Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pet Therapeutics market. It may include historical data, market segmentation by Type (e.g., Infectious Diseases, Dermatological Diseases), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pet Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pet Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pet Therapeutics industry. This include advancements in Pet Therapeutics technology, Pet Therapeutics new entrants, Pet Therapeutics new investment, and other innovations that are shaping the future of Pet Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pet Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Pet Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pet Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pet Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pet Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pet Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pet Therapeutics market.
Market Segmentation:
Pet Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Infectious Diseases
Dermatological Diseases
Orthopedic Diseases
Behavioral Disorders
Others
Segmentation by application
Dogs
Cats
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Elanco
Boehringer Ingelheim GmbH
Ceva Sante Animale
Dechra Pharmaceuticals
Eli Lilly and Company
Merck
Vetoquinol
Zoetis

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Pet Therapeutics Market Size 2019-2030 2.1.2 Pet Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030 2.2 Pet Therapeutics Segment by Type 2.2.1 Infectious Diseases 2.2.2 Dermatological Diseases 2.2.3 Orthopedic Diseases 2.2.4 Behavioral Disorders 2.2.5 Others 2.3 Pet Therapeutics Market Size by Type 2.3.1 Pet Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Pet Therapeutics Market Size Market Share by Type (2019-2024) 2.4 Pet Therapeutics Segment by Application 2.4.1 Dogs 2.4.2 Cats 2.4.3 Other 2.5 Pet Therapeutics Market Size by Application 2.5.1 Pet Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Pet Therapeutics Market Size Market Share by Application (2019-2024) 3 Pet Therapeutics Market Size by Player 3.1 Pet Therapeutics Market Size Market Share by Players 3.1.1 Global Pet Therapeutics Revenue by Players (2019-2024) 3.1.2 Global Pet Therapeutics Revenue Market Share by Players (2019-2024) 3.2 Global Pet Therapeutics Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Pet Therapeutics by Regions 4.1 Pet Therapeutics Market Size by Regions (2019-2024) 4.2 Americas Pet Therapeutics Market Size Growth (2019-2024) 4.3 APAC Pet Therapeutics Market Size Growth (2019-2024) 4.4 Europe Pet Therapeutics Market Size Growth (2019-2024) 4.5 Middle East & Africa Pet Therapeutics Market Size Growth (2019-2024) 5 Americas 5.1 Americas Pet Therapeutics Market Size by Country (2019-2024) 5.2 Americas Pet Therapeutics Market Size by Type (2019-2024) 5.3 Americas Pet Therapeutics Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Pet Therapeutics Market Size by Region (2019-2024) 6.2 APAC Pet Therapeutics Market Size by Type (2019-2024) 6.3 APAC Pet Therapeutics Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Pet Therapeutics by Country (2019-2024) 7.2 Europe Pet Therapeutics Market Size by Type (2019-2024) 7.3 Europe Pet Therapeutics Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Pet Therapeutics by Region (2019-2024) 8.2 Middle East & Africa Pet Therapeutics Market Size by Type (2019-2024) 8.3 Middle East & Africa Pet Therapeutics Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Pet Therapeutics Market Forecast 10.1 Global Pet Therapeutics Forecast by Regions (2025-2030) 10.1.1 Global Pet Therapeutics Forecast by Regions (2025-2030) 10.1.2 Americas Pet Therapeutics Forecast 10.1.3 APAC Pet Therapeutics Forecast 10.1.4 Europe Pet Therapeutics Forecast 10.1.5 Middle East & Africa Pet Therapeutics Forecast 10.2 Americas Pet Therapeutics Forecast by Country (2025-2030) 10.2.1 United States Pet Therapeutics Market Forecast 10.2.2 Canada Pet Therapeutics Market Forecast 10.2.3 Mexico Pet Therapeutics Market Forecast 10.2.4 Brazil Pet Therapeutics Market Forecast 10.3 APAC Pet Therapeutics Forecast by Region (2025-2030) 10.3.1 China Pet Therapeutics Market Forecast 10.3.2 Japan Pet Therapeutics Market Forecast 10.3.3 Korea Pet Therapeutics Market Forecast 10.3.4 Southeast Asia Pet Therapeutics Market Forecast 10.3.5 India Pet Therapeutics Market Forecast 10.3.6 Australia Pet Therapeutics Market Forecast 10.4 Europe Pet Therapeutics Forecast by Country (2025-2030) 10.4.1 Germany Pet Therapeutics Market Forecast 10.4.2 France Pet Therapeutics Market Forecast 10.4.3 UK Pet Therapeutics Market Forecast 10.4.4 Italy Pet Therapeutics Market Forecast 10.4.5 Russia Pet Therapeutics Market Forecast 10.5 Middle East & Africa Pet Therapeutics Forecast by Region (2025-2030) 10.5.1 Egypt Pet Therapeutics Market Forecast 10.5.2 South Africa Pet Therapeutics Market Forecast 10.5.3 Israel Pet Therapeutics Market Forecast 10.5.4 Turkey Pet Therapeutics Market Forecast 10.5.5 GCC Countries Pet Therapeutics Market Forecast 10.6 Global Pet Therapeutics Forecast by Type (2025-2030) 10.7 Global Pet Therapeutics Forecast by Application (2025-2030) 11 Key Players Analysis 11.1 Elanco 11.1.1 Elanco Company Information 11.1.2 Elanco Pet Therapeutics Product Offered 11.1.3 Elanco Pet Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Elanco Main Business Overview 11.1.5 Elanco Latest Developments 11.2 Boehringer Ingelheim GmbH 11.2.1 Boehringer Ingelheim GmbH Company Information 11.2.2 Boehringer Ingelheim GmbH Pet Therapeutics Product Offered 11.2.3 Boehringer Ingelheim GmbH Pet Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Boehringer Ingelheim GmbH Main Business Overview 11.2.5 Boehringer Ingelheim GmbH Latest Developments 11.3 Ceva Sante Animale 11.3.1 Ceva Sante Animale Company Information 11.3.2 Ceva Sante Animale Pet Therapeutics Product Offered 11.3.3 Ceva Sante Animale Pet Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 Ceva Sante Animale Main Business Overview 11.3.5 Ceva Sante Animale Latest Developments 11.4 Dechra Pharmaceuticals 11.4.1 Dechra Pharmaceuticals Company Information 11.4.2 Dechra Pharmaceuticals Pet Therapeutics Product Offered 11.4.3 Dechra Pharmaceuticals Pet Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 Dechra Pharmaceuticals Main Business Overview 11.4.5 Dechra Pharmaceuticals Latest Developments 11.5 Eli Lilly and Company 11.5.1 Eli Lilly and Company Company Information 11.5.2 Eli Lilly and Company Pet Therapeutics Product Offered 11.5.3 Eli Lilly and Company Pet Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Eli Lilly and Company Main Business Overview 11.5.5 Eli Lilly and Company Latest Developments 11.6 Merck 11.6.1 Merck Company Information 11.6.2 Merck Pet Therapeutics Product Offered 11.6.3 Merck Pet Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 Merck Main Business Overview 11.6.5 Merck Latest Developments 11.7 Vetoquinol 11.7.1 Vetoquinol Company Information 11.7.2 Vetoquinol Pet Therapeutics Product Offered 11.7.3 Vetoquinol Pet Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 Vetoquinol Main Business Overview 11.7.5 Vetoquinol Latest Developments 11.8 Zoetis 11.8.1 Zoetis Company Information 11.8.2 Zoetis Pet Therapeutics Product Offered 11.8.3 Zoetis Pet Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 Zoetis Main Business Overview 11.8.5 Zoetis Latest Developments 12 Research Findings and Conclusion